The Broker Innovation Lab celebrates brokers and other benefits stakeholders who have embraced the changing marketplace to position themselves and their business for future success
Alan Goforth is a freelance writer in suburban Kansas City. In addition to freelancing for several publications, he has written a dozen books about sports and other topics.
A group of 19 senators sent a letter to the U.S. Department of Health and Human Services to rethink its appeal of a recent court decision permitting the use of copay accumulator programs that help patients pay for their drugs.
The pharmaceutical giant has launched a telehealth-connected website to allow patients to directly order the weight loss drug, as well as insulin products and a migraine drug, direct from the company.
Sens. Tim Kaine and Mark R. Warner, who both have championed to lower the cost of prescription drugs, applauded Sanofi, Novo Nordisk and Eli Lilly – the three major insulin manufacturers – for slashing prices, effective Jan. 1, 2024.
The Food and Drug Administration approved 55 new treatments in 2023, representing a nearly 50% increase from the year before, with Pfizer gaining the highest number of high-profile approvals covering a wide range of illnesses.
Despite the Biden administration's numerous initiatives to crack down on the high cost of drugs, several big drugmakers will hike prices this month, with Pfizer announcing over a quarter of the increases.
After the Federal Trade Commission sent warning letters to 10 drugmakers over 100 "improper" patents, 3 chose to delist their patents from the FDA's registry, potentially accelerating the approval of generic versions.
One of the nation's largest health insurance providers was using the same AI tool, nH Predict – with an alleged 90% error rate that overrides medical judgment – that UnitedHealthcare was sued for in November.